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Clathrin-mediated endocytosis (CME) is the major
pathway of epidermal growth factor receptor
(EGFR) internalization. It is commonly believed that
CMEmediates long-term attenuation of EGFR signal-
ing by targeting the receptor for degradation. How-
ever, the EGFR can also be internalized through (a)
clathrin-independent pathway(s), and it remains un-
clear why distinct mechanisms of internalization
have evolved. Here, we report that EGFRs internal-
ized via CME are not targeted for degradation, but in-
stead are recycled to the cell surface. By contrast,
clathrin-independent internalization preferentially
commits the receptor to degradation. This finding
has profound implications for signaling, as by skew-
ing EGFR fate toward recycling rather than degrada-
tion, CME prolongs the duration of signaling. Our
data show that CME determines the longevity of
some EGFR-activated signaling pathways and that
EGF-dependent biological responses, such as DNA
synthesis, absolutely require CME. Thus, CME of
the EGFR unexpectedly has a greater impact on re-
ceptor signaling than on receptor degradation.
INTRODUCTION
Receptor tyrosine kinases (RTKs) signal through a variety of
mechanisms, thereby controlling numerous cellular functions.
Endocytosis is a major mechanism of RTK signal attenuation,
as it permits the removal of RTKs from the cell surface. A wealth
of evidence (von Zastrow and Sorkin, 2007), stemming from the
initial observation that inhibition of internalization also decreases
certain signaling mechanisms (Vieira et al., 1996), has however
dramatically changed our perception of endocytosis. Indeed en-
docytosis is an integral part of signaling, not just a mechanism of
attenuation, and it provides spatial and temporal dimensions to
signaling events. Thus, a detailed molecular description of how
the endocytic and the signaling programs are written into each
other is indispensable for our understanding of cell regulation.
The epidermal growth factor (EGF) receptor (EGFR) is one of
the best-characterized RTKs. A major mechanism of internaliza-Develotion of EGFR is clathrin-mediated endocytosis (CME), whereby
the receptor is removed from the surface via clathrin-coated
pits and then routed to the early endosomes. Here, the receptor
fate is decided: either it is recycled to the cell surface, or it is fur-
ther routed for degradation to late endosomes and lysosomes. In
recent years, a spectacular series of studies has clarified many
molecular aspects of this complex circuitry [reviewed in
(Kaksonen et al., 2006; Maldonado-Baez and Wendland, 2006;
Mukhopadhyay and Riezman, 2007; Soldati and Schliwa, 2006)].
Another route of internalization of the EGFR (Orth et al., 2006;
Sigismund et al., 2005), and of other plasma membrane proteins
(Mayor and Pagano, 2007), does not depend on the clathrin
pathway. The molecular nature of this ‘‘alternative’’ pathway is
ill-defined (Mayor and Pagano, 2007; Parton and Simons,
2007). Essentially the pathway is characterized by its insensitivity
to functional ablation of clathrin, a fact that led to its rather non-
descriptive definition of non-clathrin endocytosis (NCE). NCE is
also sensitive to cholesterol-interfering drugs; since cholesterol
is enriched in membrane rafts, the pathway is sometimes re-
ferred to as ‘‘raft-dependent’’. Finally, since caveolae (another
endocytic organelle, characterized by the presence of caveo-
lin-1 and by the absence of clathrin) are a form of raft-like struc-
ture (Parton and Simons, 2007), the pathway is sometimes re-
ferred to as ‘‘caveolar’’ or ‘‘raft/caveolar’’. This rather blurry
picture reflects our poor understanding of the molecular mecha-
nisms that regulate NCE, an issue compounded by the fact that it
is not at all clear whether NCE is a single pathway or, as appears
more likely, a mixture of pathways, possibly with partially over-
lapping characteristics (Mayor and Pagano, 2007).
Despite these difficulties an operational definition can be
attempted. Herein, we refer to NCE with the following explicit as-
sumptions: (1) our operational definition applies only to the re-
ceptor system under study, i.e., the EGFR; this does not imply
that other receptors are not internalized through NCE, but simply
that generalizations should be avoided, considering the present
state of knowledge; (2) NCE is defined, for experimental pur-
poses, by its resistance to clathrin ablation; (3) NCE is sensitive
to the cholesterol-interfering drug filipin (see below); and (4) re-
gardless of whether NCE is the product of several pathways,
they all obey the above requirements. By using this definition,
we have previously shown that the EGFR is internalized both
through CME and NCE as a function of ligand dose (Sigismund
et al., 2005). In particular, at low doses of EGF, the EGFR is pre-
ponderantly internalized through CME; at higher doses, thepmental Cell 15, 209–219, August 12, 2008 ª2008 Elsevier Inc. 209
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CME Is Dispensable for EGFR Degradationreceptor is internalized through both CME and NCE (Sigismund
et al., 2005). In the same study, we provided evidence that re-
ceptor ubiquitination is indispensable for NCE of the EGFR.
Thus, this requirement might be added to the definition of
EGFR uptake via NCE.
Here, we endeavored to assess the physiological relevance
and the cellular function(s) of the two pathways of EGFR internal-
ization. We explored their impact on EGFR internalization, fate,
and signaling. We selectively analyzed CME-mediated events
by stimulating the receptor with low doses of ligand, a condition
in which CME is the predominant pathway of internalization.
Conversely, we honed in on NCE-associated events under
conditions of high EGF in cells in which CME was specifically in-
hibited through functional ablation of clathrin or of the major cla-
thrin adaptor AP-2. Additional pharmacological (filipin) or molec-
ular (EGFR mutants) tools were also used to further corroborate
our conclusions. By exploiting this multifaceted approach, we
report here that CME does not play a major role in EGFR degra-
dation, but rather in its recycling to the cell surface in order to
maintain sustained signaling. On the other hand, EGFRs internal-
ized through NCE are efficiently degraded. Thus, the two routes
of EGFR internalization have profoundly different effects on
EGFR fate and signaling abilities.
RESULTS
CME Is Not the Major Pathway of EGFR Degradation
To analyze the relevance of CME to EGFR fate, we used HeLa
cells in which clathrin was functionally ablated by siRNA-medi-
ated knockdown (KD). Three different clathrin silencing oligos,
with appropriate mismatched controls, were used with compa-
rable results. Data obtained with one oligo (# 1) are shown in
the main text, whereas representative data obtained with the
other oligos are shown in Figure S1 (available online). In addition,
re-expression of clathrin in clathrin-KD cells could reconstitute
various clathrin-dependent phenotypes reported in this paper,
thus excluding off-target effects (Figure S2).
In clathrin-KD cells, the internalization of EGFR, at low doses
of ligand, was severely impaired, with a 5- to 6-fold reduction
in the internalization constant (Ke) (from 0.33 min
-1 to 0.06 min-1)
(Figures 1A and 1B). At higher doses of ligand, however, the ex-
tent of the inhibition was significantly lower, around 2-fold, and
the Keobs decreased from 0.16 min
-1 to 0.08 min-1 (Figures
1A and 1B). Thus, in keeping with our previous results (Sigis-
mund et al., 2005), at low doses of EGF, EGFR was predomi-
nantly internalized by CME. However, at higher doses of ligand,
NCE became substantial. From the kinetics shown in Figure 1A,
we calculated that at high EGF 60% and40% of the internal-
ization events occurred through CME and NCE, respectively (see
also Table 1, where a synopsis of all measurements performed in
this study is reported). Importantly, the relative inefficiency of the
clathrin KD to block internalization events under high EGF was
not due to incomplete ablation, as shown by the fact that the in-
ternalization of another receptor, the Transferrin Receptor (TfR),
whose internalization is completely clathrin-dependent, was al-
most completely abolished in the clathrin-KD cells (Figures 1A
and 1B).
We next assessed the impact of clathrin KD on EGFR fate. We
measured receptor degradation by following the disappearance210 Developmental Cell 15, 209–219, August 12, 2008 ª2008 Elseviof EGFR in intact cells exposed to EGF. To score the degradation
of the receptor, in this kind of assay, we used high EGF. The rate
of EGFR degradation was not markedly affected by functional
ablation of clathrin (Figure 2A), although a small but reproducible
increase in the half-life of EGFR, upon EGF stimulation, was ob-
served (T/2 70 min and 95 min in control and clathrin-KD
cells, respectively, Figure 2A). Similarly, when we measured re-
ceptor downmodulation with 125I-EGF, the kinetics of disappear-
ance of EGFR from the cell surface were comparable in control
and clathrin-KD cells (Figure 2B). Of note, the KD of clathrin
did not have major effects on a panel of other endocytic proteins,
arguing in favor of the specificity of the observed effects
(Figure 2C).
Figure 1. EGFR Internalization in Various Conditions
(A) Kinetics of EGF internalization under the various indicated conditions.
Results are the average of triplicate points (SEM < 10%) and representative
of three independent experiments (see [B]).
(B) Internalization constants and receptor number/cell were measured under
the indicated conditions. Note that at high EGF, the kinetic parameter does
not measure the actual endocytic rate constant, hence the definition of ob-
served Ke (Ke-obs, see also Wiley and Cunningham, 1982). Note also that,
both at high and low EGF, 10%–15% of the internalization events were insen-
sitive to the combined clathrin-KD and filipin treatment. This can be due to the
existence of a pathway insensitive to these two conditions, or to an incomplete
effect of the KD or of the drug treatment. We refer to this component operation-
ally as ‘‘background internalization’’; in all our calculations, this background
was subtracted, in order to obtain parameters unequivocally ascribable to
CME and NCE. Results are the average from three independent experiments
± 95% CI (confidence interval). ND, not done.er Inc.
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CME Is Dispensable for EGFR DegradationTable 1. EGFR Fate under Various Conditions
Low EGF High EGF
Total
CME
(Filipin treated)
NCE
(Clathrin KD) Total
CME
(Filipin treated)
NCE
(Clathrin KD)
125I-EGF internalizationa 100%(85% CME+NCE)d 100% 0% 100%(90% CME+NCE)d 60% 40%
125I-EGF degradationb 30% 30% 0%e 55% 30% 80%–90%
125I-EGF recyclingc ND 40% 60%–65% 15%
Various parameters, concerning EGFR internalization and fate, are summarized.
a Data on 125I-EGF internalization are extracted from the experiments presented in Figure 1.
b Data on 125I-EGF degradation are extracted from the experiments shown in Figure 3A and 4C.
c Data on 125I-EGF recycling are extracted from the experiments shown in Figure 5A. ND, not done; under low EGF the amount of internalized counts
was too low and did not allow for a reproducible estimate of recycling rates.
d The indicated range of value refers to the subtraction of ‘‘background internalization’’ (see legend to Figure 1B); 100% means total internalization,
85% and 90% (in the case of low and high EGF, respectively) refer to the values unequivocally attributable to CME + NCE after subtraction of back-
ground internalization. For all other values reported, background internalization was subtracted before calculating percentages.
e The indicated value was not directly measured (due to the extremely low number of counts internalized under this condition), and it is inferred from the
other calculations.NCE Is Preferentially Coupled to EGFR Degradation
The above results indicate that CME does not play a major role in
EGFR degradation and suggest that in order to be degraded the
EGFR must be internalized through a clathrin-independent path-
way. To gain more insights into this issue, we measured ligand
degradation with 125I-EGF.
As shown in Figure 3A, at low EGF (when CME is predomi-
nant), 30% of the internalized ligand was degraded. At high
EGF,55% of the ligand was degraded. Since under these con-
ditions60% and40% EGF enters through CME and NCE, re-
spectively, we calculated that90% of the EGF entering through
NCE is destined to degradation (detailed calculations are in the
legend to Figure 3A; see also Table 1).
To further strengthen our conclusions, we measured ligand
degradation in clathrin-KD cells under high EGF. In this case,
we detected increased ligand degradation with respect to con-
trol cells (Figure 3A). Under these conditions (in which CME is
impaired), up to 80% of 125I-EGF was degraded (Figure 3A),
which is close to the 90% theoretically calculated above (see
also Table 1). The degradation of NCE-internalized EGFR, under these
conditions, was sensitive to the lysosomal inhibitor chloroquineDevelop(Figures 3B and 3C), demonstrating that NCE routes the receptor
to lysosomal degradation. In addition, chloroquine exerted virtu-
ally indistinguishable effects on both control and clathrin-KD
cells (Figures 3B and 3C), further confirming that efficient
EGFR degradation requires receptor internalization through the
NCE pathway.
Cholesterol-interfering drugs, such as filipin, can also be used
to explore the NCE pathway. We find that filipin is preferable over
other widely used drugs, such as b-methyl-cyclodextrin or nys-
tatin, both for theoretical and experimental reasons (see
Figure S3 for details). Filipin acts selectively on NCE-mediated
internalization, as shown by its lack of effect on the internaliza-
tion of EGFR under low EGF, or of the TfR (Figures 1A and 1B).
However, at high EGF, filipin inhibited40% of all EGFR internal-
ization events, in solid agreement with the amount of NCE-medi-
ated internalization, measured in clathrin-KD cells (Figures 1A
and 1B, Table 1). Indeed, under conditions of high EGF, near-
complete inhibition of internalization could be achieved only by
combining clathrin-KD and filipin treatment (Figures 1A and
1B). We further note that the existence of two routes of internal-
ization of the EGFR, and their selective sensitivity to clathrin-KDFigure 2. EGFR Degradation and Down-
modulation in Clathrin-KD Cells
HeLa cells were subjected to clathrin KD, as
indicated, or to transfection with control oligo
(mismatch of oligo 1, Ctrl).
(A) Receptor degradation. IB was as shown. (Bot-
tom panel) Densitometry of EGFR blot. Results are
typical and representative of at least three experi-
ments.
(B) Receptor downmodulation. Results are the
average from three independent experiments ±
95% CI.
(C) HeLa cells were subjected to clathrin KD, with
three different silencing oligos, or to transfection
with control oligo (mismatch of oligo 1, Ctrl). The
expression of various endocytic proteins was
tested as shown.mental Cell 15, 209–219, August 12, 2008 ª2008 Elsevier Inc. 211
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CME Is Dispensable for EGFR DegradationFigure 3. NCE-Mediated Degradation of EGFR
(A) 125I-EGF degradation. High EGF, 20 ng/ml; low EGF, 1.5 ng/ml. Results are
the average from three independent experiments ± 95% CI. Ligand degrada-
tion in clathrin-KD cells was measured at 90 and 120 min, since the overall
reduced internalization, under this condition, did not yield sufficient counts
for reliable measurements at shorter times. Data were obtained after subtraction
of values obtained (in parallel experiments) under conditions of clathrin-KD/
filipin treatment to remove ‘‘background internalization’’ (see Figure 1). These
values never exceeded 10%–20% of the total counts. Calculation of the frac-
tion of NCE-internalized EGFR undergoing degradation: under high EGF
55% EGF is degraded, and 60% and 40% EGF enters through CME
and NCE, respectively. Since 30% EGF entering through CME is degraded,
the CME pathway contributes18% (30% of 60%) to degradation of EGF, un-
der high EGF. The remaining 37% degraded EGF (55%–18%) is attributable
to NCE. Since 40% EGF enters, under high EGF, through this route, 90%
(37/40 = 0.925) of the EGF entering through NCE is destined to degradation.
(B) Cells were treated with chloroquine (100 mM for 3 hr at 37C) and EGF (100
ng/ml) as indicated. IB was as shown.
(C) Cells were treated with chloroquine as shown and incubated with anti-
EGFR (green, 13A9) and rhodamine-EGF (red) for the indicated times. Note
that after 15 min of EGF treatment, ligand and receptor signals colocalized
in endosomes, in both control and clathrin-KD cells. At 120 min, nearly all sig-
nals disappeared in cells not treated with chloroquine, suggesting degrada-
tion. Conversely, in chloroquine-treated cells, signals persisted in vesicular
compartments and no significant differences were detected between control
and clathrin-KD cells. Blue, DAPI. Bar, 18 mm.212 Developmental Cell 15, 209–219, August 12, 2008 ª2008 Elsevior to filipin treatment, could be confirmed in three independent
populations of HeLa cells (data not shown, see the Experimental
Procedures) and also in the fibroblastic cell line NR6 (see below).
When we measured EGF degradation in the presence of filipin
under high EGF, a condition under which NCE is inhibited, we
detected a conspicuous inhibition of EGFR degradation (Fig-
ure 4A), which correlated well with the kinetics of disappearance
of EGFR from the surface under the same conditions (Figure 4B).
In this latter assay, in filipin-treated cells after an initial disap-
pearance, the receptor reappeared on the surface, suggesting
increased recycling (Figure 4B).
We then measured ligand degradation with 125I-EGF. Under
conditions of high ligand, the degradation of EGF was dramati-
cally reduced in the presence of filipin (Figure 4C). Actually, the
kinetics of degradation of high EGF in filipin-treated cells were
virtually identical to those of low EGF in control cells, further re-
inforcing the notion that NCE is required for efficient EGFR de-
gradation (see also Table 1). Of note, filipin treatment did not
have any measurable effect on the degradation of EGF at low
doses of ligand (Figure 4C). This result demonstrates that filipin
does not interfere with the degradation of EGFR when the recep-
tor is internalized through CME. It should be further added that
filipin did not interfere with the degradation of low density lipo-
protein (LDL) or of bovine serum albumin (BSA), which represent
prototypes of molecules internalized through CME or fluid phase
endocytosis, respectively, and which are normally destined to ly-
sosomal degradation (Figure S4). Thus, filipin does not interfere
with steps of endocytosis that are distal to internalization.
In summary, through two different approaches, based on mo-
lecular genetics (clathrin KD) and pharmacological interference
(filipin treatment), we demonstrated that NCE is the preferential
mode of internalization that destines the EGFR to degradation.
CME Sustains EGFR Recycling to the Cell Surface
Since we established that EGFRs internalized through CME are
committed to degradation in only 30% of the cases (Table 1),
we questioned what the fate of the remaining 70% EGFRs might
be. One possibility is that the EGFR internalized through this
route is recycled to the plasma membrane. To test this hypothe-
sis, we measured recycling in the presence of high EGF with two
different methods.
First, we followed ligand recycling using 125I-EGF. In control
HeLa cells, 40% of EGFR was recycled (Figure 5A, Table 1).
This result is congruent with the 55% degraded EGF that we
observed under the same conditions (Figure 3A, Table 1). The
impairment of CME, through clathrin KD, caused a significant
decrease in the recycling kinetics (corresponding to an 2-fold
reduction in the recycling rate; data not shown). In clathrin-KD
cells only 15% of the EGFR was recycled to the plasma mem-
brane (Figure 5A, Table 1), in excellent concordance with the es-
timated 80%–90% EGFR degraded under the same conditions
(Figure 3A, Table 1). By applying the same logic used in
Figure 3A to calculate the extent of receptor degradation, we fur-
ther calculated that 60% of the receptor internalized through
CME is recycled, a value in good agreement with the 30% de-
gradation associated with this route (Figure 3A). Treatment of
HeLa cells with filipin further confirmed these quantitative as-
sessments, as 65% of the receptors internalized under these
conditions were recycled to the surface (Figure 5A, Table 1).er Inc.
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CME Is Dispensable for EGFR DegradationFinally, independent measurements by a FACS-based assay
also showed a sizable decrease in EGFR recycling in clathrin-
KD cells compared to control cells, which was mirrored by an
Figure 4. EGFR Degradation and Downmodulation in Filipin-Treated
Cells
(A) Receptor degradation. HeLa cells were treated with filipin or mock-treated.
IB was as shown. Bottom panel, densitometry of EGFR blot.
(B) Receptor downmodulation. Results are the average from three indepen-
dent experiments ± 95% CI.
(C) 125I-EGF degradation. The experiment was performed as in Figure 3A,
including subtraction of ‘‘background internalization.’’ Results are the average
from three independent experiments ± 95% CI. The ‘‘ filipin’’ curves are the
same as in Figure3A, sinceall measurementscomefrom thesame experiments.Developequally evident increase in filipin-treated cells (Figure 5B, see
also Figure S5A for additional experiments). Of note, filipin did
not affect the recycling rate of the TfR, which is internalized ex-
clusively through CME, thus excluding nonspecific effects of
the drug on recycling (Figure S5B).
As an additional tool, we employed a mutant EGFR, Y1045F, in
which mutagenesis of a single Tyr dramatically reduces receptor
ubiquitination (Figure S6A; Levkowitz et al., 1999). Since we pre-
viously showed that EGFR ubiquitination is indispensable for
NCE, but dispensable for CME (Sigismund et al., 2005), we pre-
dicted that EGFR-Y1045F would be internalized almost exclu-
sively through CME. In addition, since this mutant cannot be
ubiquitinated, it should not be routed to late endosomal stations
and might be recycled back to the cell surface with high effi-
ciency. We used NR6 fibroblasts, devoid of EGFR (Pruss and
Herschman, 1977), to perform experiments with the Y1045F mu-
tant. We expressed either EGFR wt or the Y1045F mutant at
comparable levels in these cells (Figure S6B). Although the kinet-
ics of internalization of the EGFR displayed some difference with
respect to HeLa cells (see Figures S6B and S6C for details), as
expected the Y1045F mutant was internalized almost exclusively
through CME, both at low and high EGF (Figures S6B and S6C).
In addition, EGFR-Y1045F displayed reduced degradation and
increased recycling when compared to the wt receptor (Figures
S6D and S6E). Of note, 70% of the Y1045F mutant was re-
cycled to the cell surface. Since these latter results were ob-
tained in the absence of functional ablation of components of
the clathrin pathway, or of pharmacological interference, they
show that the CME pathway possesses the intrinsic ability to
sustain high rates of recycling of the EGFR.
Intracellular Trafficking of NCE-Internalized EGFRs
On the basis of the above experiments, we concluded that the
EGFR undergoes profoundly different fates, depending on the
engaged pathway of internalization (CME versus NCE). CME-in-
ternalized receptors are predominantly recycled to the cell
surface and only a fraction of these receptors is committed to
degradation. Conversely, NCE-internalized receptors are pre-
dominantly destined for degradation and they show little, if
any, recycling to the plasma membrane. Current knowledge
holds that internalized EGFR is routed to early endosomes,
where its fate (recycling or degradation) is decided. An obvious
question, therefore, is whether NCE-internalized receptors are
trafficked through the canonical endosomal pathway or through
a different route. To gain insights into this issue, we investigated
the colocalization of rhodamine-EGF with endosomal (early, late,
recycling) and lysosomal markers. We performed these experi-
ments in clathrin-KD cells under high EGF, a condition that al-
lows for the quasi-selective exploration of NCE. We found that
EGF colocalized with EEA-1 (early endosomes) comparably in
clathrin-KD and control cells (Figure 5C). As expected, based
on all previous evidence, EGF showed increased colocalization
with late endosomes (Rab7) and lysosomes (Lamp2), and de-
creased colocalization with a marker of recycling endosomes
(Rab11) in clathrin-KD cells. These results, coupled with the pre-
vious demonstration that NCE-internalized EGFRs are degraded
in the lysosome (Figures 3B and 3C), indicate NCE-internalized
receptors are trafficked through a canonical endosomal route.
Finally, as expected from the results shown so far, EGFmental Cell 15, 209–219, August 12, 2008 ª2008 Elsevier Inc. 213
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CME Is Dispensable for EGFR DegradationFigure 5. EGF and EGFR Recycling and
Degradation
(A) 125I-EGF recycling. Results are the average
from three independent experiments ± 95% CI.
(B) EGFR recycling measured by FACS. ‘‘Pulse,’’
surface EGFR was measured in starved cells,
before (gray area) or after a 15 min pulse of EGF
(100 ng/ml, white area). Panels ‘‘10 min’’ and
‘‘20 min,’’ surface EGFR was measured (gray
areas) 10 and 20 min after the pulse (white areas,
surface EGFR at pulse time). RSL, relative surface
level (see the Supplemental Experimental Procedures).
(C) Colocalization of EGF and various endocytic
markers. HeLa cells (transfected where indicated
with Rab7-GFP or Rab11-GFP), were subjected
to control siRNA (control) or clathrin KD. Cells
were then incubated with rhodamine-EGF (0.5
mg/ml, red) for 10 min (for the detection of colocal-
ization with EEA1) or 30 min (for the detection of
colocalization with Rab7, Rab11, Lamp-2), and
stained (green) for EEA-1 or Lamp-2; Rab7 and
Rab11 were detected by epifluorescence. Merged
channels are shown. Bar, 18 mm. Results are typ-
ical and representative of three experiments. The
percent of colocalization of rhodaminated-EGF
with the various markers (% intensities above
threshold) is also shown; *, p < 0.05 with respect
to ‘‘control.’’internalized through CME (filipin treatment) showed reduced
colocalization with markers of late endosomes and lysosome,
and increased colocalization with Rab11 (Figure S5C).
CME Sustains Prolonged EGFR Signaling
We have demonstrated that CME does not represent a major
mechanism of EGFR attenuation, but its physiological role re-
mains undefined. Endocytosis has been linked to both signaling
attenuation and to signaling enforcement; thus, we investigated
the impact of CME (and of NCE) on EGFR receptor signaling. As
before, our experimental strategy relied on the fact that functions
connected with CME can be explored in HeLa cells stimulated
with low EGF, whereas NCE-associated phenotypes can be in-
vestigated in clathrin-KD cells stimulated with high EGF. As
shown in Figure 6, both under low or high EGF, the kinetics of
phosphorylation of different substrates (AKT, ERKs, SHC) in con-
trol HeLa cells were biphasic, with a rapid peak (5 min) followed
by a slow decay.
In the case of P-AKT (and to a lesser extent also in the case of
P-ERKs), clathrin KD did not have much effect on the peak phase
(some reduction was observed at low EGF), but severely damp-
ened the decay phase (Figures 6A and 6B). Thus, prolonged sig-
naling requires CME for certain pathways. A straightforward in-
terpretation of these results is that the peak phase of signaling
is endocytosis-independent (probably exclusively originated at
the plasma membrane), while a sustained decay phase requires
CME. In the case of P-SHC, conversely, the kinetics of phos-
phorylation were not disturbed by clathrin KD (Figures 6A and
6B), arguing for their CME-independence.
A corollary of the above findings is that under conditions in
which NCE is inhibited, the kinetics of phosphorylation of sub-
strates such as AKT or ERKs should be altered and should dis-
play a sustained decay phase. Indeed, when HeLa cells were214 Developmental Cell 15, 209–219, August 12, 2008 ª2008 Elsevitreated with filipin and high EGF, there was increased phosphor-
ylation of AKT and ERKs, during the decay phase, with no effect
on the peak phase (Figures 6C and 6D). Importantly, under low
EGF (a condition in which CME is preponderant), filipin did not
alter the kinetics of phosphorylation of AKT and ERKs, thus ex-
cluding nonspecific effects of the drug. As expected, based on
the previously described results, the kinetics of P-SHC were
not altered by filipin treatment (Figures 6C and 6D).
To further corroborate these conclusions, we used the Y1045F
mutant, which by being continuously recycled to the cell surface,
and being subjected to very limited degradation, should pheno-
copy the effects of filipin on EGF-activated signaling. Indeed, as
shown in Figures 6E and 6F, EGF stimulation of Y1045F resulted
in an enhancement of the decay phase of phosphorylation of
AKT (and to a lesser extent of ERKs), in the absence of noticeable
alterations of the peak phase. Importantly, filipin treatment did
not further enhance signaling by the Y1045F mutant
(Figure 6E), thus arguing that, in accordance with the initial hy-
pothesis, the Y1045F mutant phenocopies the signaling effects
of filipin.
CME-Mediated Signaling Is Necessary for the Biological
Functions of EGFR
One important caveat to address, in the interpretation of the
above results, concerns a possible signaling role of clathrin.
Emerging evidence, indeed, points to a function of clathrin in
the assembly of signaling complexes at the endosome, as well
as to a direct role in transcription (reviewed in Mills, 2007).
Thus, it is important to assess whether the signaling effects of
clathrin KD are due to the impairment of CME or to the perturba-
tion of other ‘‘signaling’’ functions of clathrin.
To gain insights into this issue, we interfered with CME by an
alternative approach, i.e., through the ablation of AP-2. Weer Inc.
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CME Is Dispensable for EGFR DegradationFigure 6. CME- and NCE-Dependent EGFR Signaling
(A–D) HeLa cells were subjected to clathrin KD (A) or treated with filipin (C), and treated with EGF as indicated. IB was as shown. In (B) and (D), a semiquantitative
evaluation of (A) and (C), respectively, is reported. Densitometry was performed on different exposures of the blots and average results are reported, as arbitrary
unit (a.u.) for P-AKT and P-SHC. The half-time of the decay of the P-AKT signals was also estimated in control cells, under low or high EGF, in four independent
experiments and yielded the following results: low EGF, 25–30 min, high EGF 35–40 min.
(E and F) NR6 cells, transfected with wt EGFR or the Y1045F mutant, were treated with EGF (100 ng/ml) as indicated. IB was as shown (E). Results are typical and
representative of at least three experiments. A densitometric analysis (performed as in [B] and [D]) is reported in (F).Developmental Cell 15, 209–219, August 12, 2008 ª2008 Elsevier Inc. 215
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CME Is Dispensable for EGFR DegradationFigure 7. The KD of AP-2 Phenocopies the
Clathrin KD
HeLa cells were or subjected to AP-2- (a subunit)
or clathrin KD.
(A) 125I-EGF recycling. Results are the average
from three independent experiments ± 95% CI.
(B) KD cells, treated as shown, were IB with the
indicated Abs. Results in all panels are typical
and representative of at least three experiments.
A densitometric analysis of P-AKT signals is
reported in the lower panel.
(C) DNA synthesis was monitored by BrdU incor-
poration. Results are expressed as fold induction,
normalized to incorporation in serum-starved cells
not treated with EGF (assumed as 1). Results are
the average from three independent experiments
± 95% CI.performed KD of the a subunit (Table 1, Figure 7) or of the m sub-
unit (data not shown) with comparable results. Of note, no direct
‘‘signaling’’ functions have been described for AP-2. The KD of
AP-2 reduced the CME component of EGF internalization, while
leaving the NCE component unaltered (Table 1). As previously
reported (Huang et al., 2004), the effects on EGF internalization
of the AP-2 KD were of a lesser magnitude with respect to the
clathrin KD. This was not due to inefficient ablation (see effects
on Tf internalization, Table 1), and probably depends on the ex-
istence of alternative adaptors. However, the AP-2 KD reduced
EGF recycling as efficiently as the clathrin KD (Figure 7A) and
did not significantly affect EGFR degradation (Figure 7B, panel
EGFR). Importantly, when signaling was analyzed, we detected
in AP-2-KD cells the same alterations in the kinetics of P-AKT
(and of P-ERK1/2) as in clathrin-KD cells, while P-SHC kinetics
were unaffected (Figure 7B). Thus, two independent ways of
affecting CME (clathrin KD or AP-2 KD) have the same effects
on signaling.
The availability of AP-2-KD cells (in addition to clathrin-KD
cells) also allowed us to explore the impact of CME on biological
endpoints of EGF stimulation. We monitored EGF-induced DNA
synthesis. Both the KDs of AP-2 and clathrin substantially re-
duced this biological endpoint, when compared to control cells,
both at high and low EGF doses (Figure 7C). Thus, CME is re-
quired not only to sustain short-term EGFR signaling (Figure 6),
but also for its long-term biological effects.
It is well known that EGF-stimulated DNA synthesis and mito-
genic response exhibit a bell-shaped dose-response curve, in
which low concentrations of EGF have stronger effects than
higher concentrations (see for instance Di Fiore et al., 1987).
This is probably due to the fact that high doses of EGF induce
acute downmodulation of the receptor. We reasoned that, under
conditions of filipin treatment in which only CME is active, this ef-
fect should be reverted. As shown in Figure 7C, in control HeLa
cells, low EGF was 3-fold more efficient at inducing DNA syn-
thesis than high EGF. However, in the presence of filipin treat-
ment, low and high concentrations of EGF were equally potent.
These results support the idea that CME is required for sustained
signaling and also provide a mechanistic framework for the216 Developmental Cell 15, 209–219, August 12, 2008 ª2008 Elsevidifferent biological outcomes observed when challenging cells
with different concentrations of EGF under physiological
conditions.
DISCUSSION
Integration of Different Endocytic Routes
in EGFR Signaling and Attenuation
Our results highlight an unexpected picture of how endocytosis
regulates EGFR signaling and attenuation. At low EGF, when
CME is predominant, a large fraction of the receptor (roughly
two thirds) is recycled to the cell surface and only one third of
EGFR is destined to degradation. This, in turn, allows for
prolonged CME-dependent signaling. At high EGF, while CME
continues to be operational, NCE kicks in and destines a sizeable
part of the receptor to degradation, thereby protecting the cell
from overstimulation. Interestingly, this dual mechanism seems
to be well designed to cope with the vast variety of physiological
EGF concentrations, which range from fractions to hundreds of
nanograms per ml, in bodily fluids (reviewed in Sigismund
et al., 2005).
While somehow surprising, it is important to note that our re-
sults do not contradict any extant body of knowledge. Under
our conditions of analysis, the EGFR is internalized with Ke sim-
ilar to those reported in the literature (see for instance Huang
et al., 2004), and it is ‘‘canonically’’ routed to early endosomes.
Then it is either recycled to the cell surface (with kinetics compa-
rable to previously reported ones; see for instance Kornilova
et al., 1996) or destined to lysosomes for degradation (with
half-life comparable to the previously reported one; see for in-
stance Stoscheck and Carpenter, 1984). However, we provide
a new outlook on how these events are achieved through the
combined (and by-and-large opposing) action of two different in-
ternalization mechanisms. We performed a thorough quantita-
tive analysis of EGFR internalization, degradation, recycling,
and signaling, under conditions in which we selectively allowed
only one of the two pathways (either CME or NCE) to be prefer-
entially operational in any given experiment. When added up,
the numeric values obtained under these selective conditionser Inc.
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well, at various doses of EGF, demonstrating significant internal
consistency. Thus, through the dissection of the relative contri-
bution of CME and NCE, we identified specific functions exe-
cuted by the two pathways, which were previously attributed
globally to the clathrin-mediated pathway alone.
CME and Signaling
Our results indicate that the major function of EGFR-CME is to
sustain signaling. This seems to be a global property of the path-
way, rather than the result of putative signaling properties of
some of its components, since comparable results were
obtained using two different molecular tools, the KD of clathrin
and that of AP-2. Our detailed kinetic analysis revealed that
some signaling pathways (AKT and ERK) require intact CME,
while others (SHC) do not. In addition, the execution of complex
biological functions, such as EGFR-activated DNA synthesis,
depends on functional CME. The sum of our results is consistent
with the interpretation that the initial phase of signaling (the peak
phase) is endocytosis-independent, probably occurring at the
plasma membrane, while later events (the decay phase) require
CME. In turn, this is perfectly compatible with the fact that CME
sustains recycling, a function that is expected to have a delayed
impact on phosphorylation kinetics.
An important role of internalization in signaling is well
documented (von Zastrow and Sorkin, 2007). This has been
largely attributed to the ability of endosomes (the so-called ‘‘sig-
naling endosomes’’) to serve as an intracellular platform, confer-
ring signal specificity and diversity, possibly by extending and
segregating the repertoire of regulatory molecules and/or effec-
tors (see for instance Mor and Philips, 2006). Our results point to
an additional mechanism, through which CME contributes to sig-
naling, i.e., recycling. Recycling can impact on signaling in two
ways. Continuous recycling of receptors to the plasma mem-
brane would allow for multiple cycles of signaling from both the
plasma membrane and the endosome, preserving the receptor
from degradation: a mechanism that could be particularly advan-
tageous under conditions of limited ligand availability. Recycling
might also permit the relocalization of the receptor (or of associ-
ated signaling machinery) to regions of the plasma membrane
where spatially restricted signaling is required for events such
as actin dynamics and cell motility. Indeed there is growing evi-
dence that endocytosis is required to ensure the spatial resolu-
tion of stimuli originating from motogenic receptors, and to or-
chestrate localized actin dynamics, polarized protrusive
activity, and directed cell motility (Emery and Knoblich, 2006;
Jekely et al., 2005; Marco et al., 2007; Wang et al., 2006).
Sorting of the EGFR toward Degradation or Recycling
While the majority of CME events lead to recycling, a fraction of
them (30%) appear to commit the EGFR to degradation. One
might ask, therefore, whether this is stochastic or determined
mechanistically, for instance through molecular differences be-
tween the coated pits that internalize EGFR destined to recycling
or to degradation. The proposition is not implausible, since re-
cent results suggest the existence of cargo-specific CME routes
[see for instance (Puthenveedu and von Zastrow, 2006; Sorkin,
2004; Tosoni et al., 2005)]. The question is whether an individual
cargo species, such as EGFR, can be internalized throughDevelopmolecularly different (at least in part) coated pits, and if this
has functional consequences. We note that functional ablation
of AP-2, the major clathrin adaptor, only abrogates 50% of
CME-dependent EGFR internalization (as measured at low
EGF). This is in line with previous results (Huang et al., 2004)
and with the existence of alternative adaptors. However, the per-
turbations induced by the AP-2 KD on recycling and signaling
were quantitatively very comparable to those induced by the cla-
thrin KD, suggesting that the fraction of CME that is AP-2-depen-
dent is the one associated with recycling and recycling-depen-
dent signaling. In turn, this allows speculation that EGFRs
internalized through coated pits formed by adaptors other than
AP-2 might be those subjected to CME-dependent degradation
(Lakadamyali et al., 2006). The issue of whether different EGFR-
internalizing pits are coupled with different functional outcomes
appears, therefore, worthy of future investigations.
A related issue concerns the trafficking pattern of the EGFR,
internalized through CME or NCE. We were able to ascertain
that EGFRs internalized through either pathway were routed to
early endosomes. It remains to be established how they are dif-
ferentially sorted to recycling (in the case of CME) or to degrada-
tion (in the case of NCE). One obvious possibility stems from ev-
idence that clathrin might be required for endosomal sorting and
recycling (Newmyer and Schmid, 2001; van Dam and Stoorvo-
gel, 2002), a function that might be related to the demonstrated
assembly of endosomal coats containing clathrin and Hrs (Rai-
borg et al., 2002). Thus, sorting of EGFR at the endosome might
also be partially clathrin-dependent, and sensitive to clathrin KD.
However, the KD of AP-2 phenocopied the KD of clathrin, as far
as sorting to a recycling fate was concerned. Of note, there is no
evidence that AP-2 is involved in endosomal sorting. Thus,
alternative possibilities should also be considered. One such
possibility is that molecular determinants carried by CME- or
NCE-originated vesicles affect sorting in endosomes. Clearly,
more work will be needed to distinguish among these and other
hypotheses.
The Nature of the NCE Pathway
Our results establish that the major function of NCE is to commit
the EGFR to degradation. This was established through two ap-
proaches: by analyzing a series of parameters under conditions
in which NCE was preferentially active (in clathrin-KD cells) or by
inhibition of NCE with filipin. The two approaches yielded quan-
titatively complementary results, thus providing internal valida-
tion. In addition, the extent of EGFR degradation scored in the
presence of filipin and under high EGF was almost identical to
that detected in control cells treated with low EGF (in the
absence of the drug). Therefore, two distinct ways to explore
selectively the CME pathway yielded the same results.
Much remains to be understood. Our results, while shedding
light on the role of NCE in EGFR physiology, do not address its
molecular mechanisms. We would like to expressly state that
nothing in our data should be taken to indicate support for
a role of caveolae in EGFR-NCE. We have shown that under
high EGF there is increased localization of the EGFR to caveolae
(Sigismund et al., 2005). This, however, does not imply that NCE
occurs through them. Indeed, we show here that NCE of EGFR is
caveolin-1-independent (see Figure S7, where literature in dis-
agreement with our findings [Kazazic et al., 2006] is alsomental Cell 15, 209–219, August 12, 2008 ª2008 Elsevier Inc. 217
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NCE is a single pathway or a combination of pathways. Regard-
less, we note that even if multiple pathways should contribute to
NCE, their nature seems to be cumulatively degradative.
Our results clearly establish that, in the case of the EGFR, the
recycling/signaling and the degradative fates are preferentially
associated with different endocytic routes. This raises one final
question: are these generalized properties of CME and NCE?
We note that in the case of the TGF-b receptor a situation similar
to that described here has been reported (Di Guglielmo et al.,
2003). However, until a clear molecular picture of NCE is
acquired, caution is appropriate and conclusions should remain
restricted to the model under experimental scrutiny.
EXPERIMENTAL PROCEDURES
Chemicals, Antibodies, and Cells
A detailed list of all chemicals and antibodies used is in the Supplemental Ex-
perimental Procedures. HeLa or NR6 cells were transfected with FuGENE 6
(Roche) or OligofectAMINE (Invitrogen). For filipin treatment, cells were se-
rum-starved for 4 hr and then preincubated for 1 hr with 0.5–1 mg/ml of filipin
(SIGMA), followed by the indicated experimental procedures. In each experi-
ment, internalization of 125I-Tf was measured (data not shown), to exclude
nonspecific effects. The experiments reported in this study were performed
on an in-house population of HeLa cells. However, results on internalization
and receptor degradation were confirmed on two additional populations of
HeLa cells, one purchased from ATCC and one corresponding to the isolate
HeLa ‘‘Kyoto’’ (Neumann et al., 2006).
Biochemical Assays
Lysis and immunoblotting (IB) were as described (Penengo et al., 2006). Quan-
tification of blots was performed with ImageJ.
EGFR total surface levels were measured by saturation binding assays with
iodinated ligands as described (Tosoni et al., 2005).
Internalization of 125I-EGF and 125I-Tf, and recycling and degradation of
125I-EGF, were performed as described (Haglund et al., 2003; Kornilova
et al., 1996; Sorkin et al., 1991a, 1991b; Tosoni et al., 2005). Additional details
are in the Supplemental Experimental Procedures.
For the downmodulation assay, cells were serum-starved for 4 hr and then
incubated with EGF (100 ng/ml) at 37C for the indicated time points. Cells
were then subjected at 4C to ‘‘mild acid/salt treatment’’ (0.2 M Na Acetate
buffer [pH 4.5], 0.5 M NaCl) to remove bound EGF, followed by measurement
of surface EGFR by saturation binding with 125I-EGF.
Functional Ablation of Clathrin or AP-2
Silencing of clathrin heavy chain or of AP-2 in HeLa cells was by transient
transfection of siRNA oligos (from Dharmacon or Invitrogen) as described
(Motley et al., 2003). Three different RNAi oligos (sequences are in the Supple-
mental Experimental Procedures) were used to target the clathrin heavy chain.
For each oligo, a mismatched control was designed by introducing at least four
mutations in the sequence (see the Supplemental Experimental Procedures).
In each assay, at least two (of three) targeting oligos were used with compara-
ble results.
Methodologies for reconstitution of clathrin in KD cells and for the silencing
of clathrin in NR6 cells are in the Supplemental Experimental Procedures.
Two different RNAi oligos were used to target AP-2 (from Dharmacon, se-
quences are in the Supplemental Experimental Procedures). In each assay,
the two oligos yielded comparable results.
Colocalization Studies
Internalization assays of fluorochrome-conjugated ligands and immunofluo-
rescence analysis were performed as described (Haglund et al., 2003; Tosoni
et al., 2005). The ImageJ software (W. Rasband, National Institutes of Health,
Bethesda, MD, USA) was used for quantitative analysis on an average of 6–8
cells per condition. Background intensity was initially subtracted by placing
‘‘Regions of Interest’’ (ROI) over areas devoid of specific signal. The colocali-218 Developmental Cell 15, 209–219, August 12, 2008 ª2008 Elsevzation analysis plug-in (T. Collins, WCIF, Toronto Western Research Institute,
Toronto, Canada) provided the reported percentage of colocalized intensity for
each channel. Colocalizing intensity pixels were calculated above a specific
intensity threshold (subsequently normalized to total channel intensity) giving
the reported % intensities colocalized above threshold.
BrdU Incorporation Studies
HeLa cells (50% confluency) were serum starved for 24 hr and pretreated
with filipin (0.5 mg/ml for 30 min at 37C) or mock treated, followed by incuba-
tion with EGF for 8 hr at 37C, in the presence or absence of filipin. BrdU
(33.3 mM) was then added for 30 min. Detection was with an anti-BrdU anti-
body (Becton Dickinson). Additional details are in the Supplemental Experi-
mental Procedures.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and
seven figures and are available online at http://www.developmentalcell.com/
cgi/content/full/15/2/209/DC1/.
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